This study examined whether exposure of pigs to both porcine respiratory coronavirus (PRCV) and bacterial lipopolysaccharide (LPS) can potentiate respiratory disease and lung secretion of tumour necrosis factor-á (TNF-á) and interleukin-1 (IL-1). Caesarianderived colostrum-deprived pigs were inoculated intratracheally with PRCV, with LPS from Escherichia coli O111:B4 (20 ìg=kg), or with a combination of the two, and killed at set times after inoculation. Clinical signs, virus replication and (histo)pathological changes in the lungs, percentage of neutrophils and bioactive TNF-á and IL-1 in broncho-alveolar lavage (BAL)¯uids were examined. The effects of separate virus or LPS inoculations were subclinical and failed to induce high and sustained cytokine levels. In a preliminary study, pigs were inoculated with PRCV and then with LPS 24 h later and killed sequentially. Severe respiratory disease and signi®cantly enhanced TNF-á titres (208±3601 U=ml versus 40±89 U=ml after LPS only) were seen during the ®rst 12 h after LPS inoculation. IL-1 levels (106±1631 U=ml versus 28±654 U=ml after LPS only) were also increased, but persisted for longer after clinical recovery than TNF-á. In a second study, pigs were inoculated with PRCV and subsequently with LPS at various time intervals ranging from 0 to 24 h, and killed 5 h after inoculation with LPS. A time interval of at least 12 h between inoculations was necessary for prominent respiratory signs to develop. Production of TNF-á, but not IL-1, was also dependent on the time interval between inoculations and was tightly correlated with disease. Lung neutrophil in®ltration and pathological changes were comparable after combined PRCV-LPS and single LPS inoculations, and were not associated with disease. These data show that exposure to high endotoxin concentrations in swine buildings can precipitate respiratory disease in PRCV-infected pigs, and that TNF-á is probably an important mediator of these effects. This is the ®rst in-vivo demonstration of synergy between respiratory viruses and LPS.